Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FH3H6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,055
Award facts
- Contract value 100% obligated
- $11,055.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,055.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 26, 2025. This award was competitively procured with no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical supply needs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected based on its demonstrated capability to meet federal procurement standards through open competition. The company's extensive federal contract portfolio with the Defense Logistics Agency encompasses a broad range of pharmaceutical products and medical supplies serving military healthcare systems, the Defense Health Agency, and other government healthcare organizations. This delivery order for Enbrel, a biologic therapy commonly used for rheumatoid arthritis and other autoimmune conditions, is consistent with AmerisourceBergen's established role in supplying specialty medications and branded pharmaceutical products to support the military health system's medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DB25FH3H6?
SPE2DB25FH3H6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FH3H6 worth?
The government has obligated $11,055 on SPE2DB25FH3H6.
Is contract SPE2DB25FH3H6 an order under another contract?
Yes. SPE2DB25FH3H6 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH3H6 competed?
The extent of competition for SPE2DB25FH3H6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award